The largest database of trusted experimental protocols

5 protocols using 14c inulin

1

Radiolabeled Compounds for Cellular Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
[14C]Urate (55.0 mCi/mmol), [3H]guanine (10.7 Ci/mmol), [3H]hypoxanthine (27.0 Ci/mmol), [3H]thymine (65.0 Ci/mmol), and [3H]uracil (42.8 Ci/mmol) were obtained from Moravek Biochemicals (Brea, CA), [14C]inulin (1.9 mCi/g) was from American Radiolabeled Chemicals (St. Louis, MO), and [3H]polyethylene glycol 4000 (PEG 4000, 1.5 mCi/g) was from PerkinElmer Life Sciences (Boston, MA). Unlabeled urate, guanine, hypoxanthine, thymine, and uracil were obtained from Wako Pure Chemical Industries (Osaka, Japan), and Ko143 was from Sigma‐Aldrich (St. Louis, MO). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were obtained from Wako Pure Chemical Industries and Invitrogen (Carlsbad, CA), respectively. Mouse monoclonal antibodies for the tag peptides of DYKDDDDK (FLAG) and hemagglutinin (HA) were obtained from Wako Pure Chemical Industries (product numbers of 014‐21881 and 018‐22381, respectively, for the anti‐FLAG and anti‐HA antibodies), and a mouse monoclonal antibody for β‐actin (product number A5441) and horseradish peroxidase‐conjugated goat anti‐mouse IgG (product number A8924) were from Sigma‐Aldrich. All other reagents were of analytical grade and commercially obtained.
+ Open protocol
+ Expand
2

In-vivo Clearance of 125I-Aβ40 via BEI Method

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in-vivo 125I-Aβ40 (PerkinElmer; Boston, MA, USA) clearance was investigated using the brain efflux index (BEI) method as we described previously [20 (link)]. In brief, at the end of the treatment, animals were intraperitoneally anesthetized with xylazine and ketamine (20 and 125 mg/kg, respectively), followed by the insertion of a stainless-steel guide cannula into the right caudate nucleus, an area rich with blood microvessels, of the mice’s brain following previously established protocols [58 (link)]. A tracer fluid (0.5 μL) containing 125I-Aβ40 (30 nM; PerkinElmer, MA, USA) and 14C-inulin (0.02 mCi, American Radiolabeled Chemicals, St. Louis, MO, USA), prepared in an artificial extracellular fluid buffer (ECF; 122 mM NaCl, 25 mM NaHCO3, 3 mM KCl, 1.4 mM CaCl2, 1.2 mM MgSO4, 0.4 mM K2HPO4,10 mM D-glucose, and 10 mM HEPES, pH 7.4), was microinjected in the mice brains. Thirty minutes later, the brains were rapidly collected for a 125I-Aβ40 analysis. 125I-Aβ40 and 14C-inulin radioactivity was determined in the brain tissues using Wallac gamma and beta counters (PerkinElmer Inc. Waltham, MA, USA), respectively. 125I-Aβ40 BEI was determined using the formula:
+ Open protocol
+ Expand
3

In Vivo Amyloid-beta Clearance Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo Aβ40 clearance was investigated using the
BCI method as described previously.36 (link) Animals
were anesthetized followed by the insertion of a stainless steel guide
cannula into the right caudate nucleus of mice brains. A tracer fluid
(0.5 μL) containing 125I-Aβ40 (30
nM, PerkinElmer, MA) and 14C-inulin (0.02 mCi, American
Radiolabeled Chemicals, MO) prepared in extracellular fluid buffer
(ECF) was microinjected. Thirty minutes later, brains were rapidly
collected. One hemisphere of the brain was used for 125I-Aβ40 analysis and the second hemisphere was used
for microvessels isolation as described below. Calculations of 125I-Aβ40 clearance were performed as described
previously.36 (link) Using trichloroacetic acid
(TCA) precipitation intact (precipitate) and degraded (supernatant) 125I-Aβ40 were determined in brain tissue
using a Wallac 1470 Wizard Gamma Counter (PerkinElmer, MA). 14C-Inulin in the precipitate and supernatant were also determined
using a Wallac 1414 WinSpectral Counter (PerkinElmer). The 125I-Aβ40 brain clearance index (BCItotal(%)) and clearance of 125I-Aβ40 across
BBB (BCIBBB(%)) were determined as described previously.36 (link)
+ Open protocol
+ Expand
4

Measurement of Aβ40 Clearance in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo Aβ40 clearance was investigated using the BEI method in C57BL/6 wild-type mice as described previously.53 (link) Animals were anesthetized followed by the insertion of a stainless steel guide cannula into the right caudate nucleus of mice brains. A tracer fluid (0.5 μL) containing 125I-Aβ40 (link) (30 nM, PerkinElmer, MA) and 14C-inulin (0.02 mCi, American Radiolabeled Chemicals, St. Louis, MO) prepared in extracellular fluid buffer (ECF) was microinjected in the mice brains. Thirty minutes later, brains were rapidly collected for 125I-Aβ40 analysis and microvessels isolation as described below. Calculations of 125I-Aβ40 clearance were performed as described previously.53 (link) 125I-Aβ40 and 14C-inulin radioactivity were determined in brain tissues using a Wallac beta and gamma counter. 125I-Aβ40 BEI% was determined as described previously.53 (link)
+ Open protocol
+ Expand
5

Investigating Aβ40 Clearance In Vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo Aβ40 clearance was investigated using the BEI method as described previously (Qosa et al., 2012 (link)). In brief, a stainless steel guide cannula was implanted stereotaxically into the right caudate nucleus of mice that had been anesthetized with intraperitoneal xylazine and ketamine (20 and 125 mg/kg, respectively) (Henry Schein Inc., NY). After 12 h recovery period, animals were re-anesthetized and tracer fluid (0.5 μl) containing 125I-Aβ40 (30 nM, PerkinElmer, MA) and 14C-inulin (0.02 μCi, American Radiolabeled Chemicals, MO) prepared in extracellular fluid buffer (ECF) was administered. Thirty minutes post 125I-Aβ40 injection (Cirrito et al., 2005 (link); Shibata et al., 2000 (link)); brain tissues were rapidly collected for 125I-Aβ40 analysis. To characterize role of P-gp and LRP1, 0.5 μl of ECF containing valspodar (40 μM; XenoTech, KS), a well-established P-gp inhibitor, or RAP (1 μM; Oxford Biomedical Research, MI), an LRP1 inhibitor, were intracerebrally administered 5 min prior to 125I-Aβ40 injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!